COlchicine iN Circulating Inflammatory Markers After StrokE (CONCISE)

NCT06062277 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

91

Enrollment

OTHER

Sponsor class

Conditions

Ischemic Stroke
Atherosclerosis

Interventions

DRUG: Colchicine 0.5 MG

Sponsor

University College Dublin

Collaborators

[object Object]